Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infections, Respiratory in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantu, J; Geyer, R; Jett, M; Jo, SC; Mani, S; Moss, OR; Peacock, AD; Saxton, AM; White, DC1
Metcalfe, DD; Raphael, GD1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory

ArticleYear
Mediators of airway inflammation.
    European journal of respiratory diseases. Supplement, 1986, Volume: 147

    Topics: Arachidonic Acids; Free Radicals; Histamine Release; Humans; Immunity, Cellular; Inflammation; Mast Cells; Membrane Lipids; Models, Biological; Platelet Activating Factor; Prostaglandins; Respiratory Tract Infections

1986

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infections, Respiratory

ArticleYear
Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology.
    Journal of microbiological methods, 2005, Volume: 62, Issue:3

    Topics: Actinobacillus pleuropneumoniae; Animals; Breath Tests; Cell Line; Chromatography, High Pressure Liquid; Eicosanoids; Enterotoxins; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lipopolysaccharides; Lung Diseases; Phospholipids; Platelet Activating Factor; Rats; Respiratory Tract Infections; Spectrometry, Mass, Electrospray Ionization; Sus scrofa

2005